OIR to Review Charges of HIV Rx Drug Discrimination in ACA Plan Filings
The Florida Office of Insurance Regulation (OIR) is reviewing ACA plan filings that were due on May 15 to determine whether there is discrimination in coverage of HIV prescription drugs under the plan formularies. In a memo (attached) issued by OIR on March 25, OIR directed insurers to refer to